Related references
Note: Only part of the references are listed.Predictors of slow progression to diabetes in children with multiple islet autoantibodies
Andrea K. Steck et al.
JOURNAL OF AUTOIMMUNITY (2016)
Innate inflammation in type 1 diabetes
Susanne M. Cabrera et al.
TRANSLATIONAL RESEARCH (2016)
Role of pro-inflammatory cytokines of pancreatic islets and prospects of elaboration of new methods for the diabetes treatment
Marek Cieślak et al.
ACTA BIOCHIMICA POLONICA (2015)
Health Care Utilization and Costs of Publicly-Insured Children with Diabetes in California
Joyce M. Lee et al.
JOURNAL OF PEDIATRICS (2015)
Regulatory vs. inflammatory cytokine T-cell responses to mutated insulin peptides in healthy and type 1 diabetic subjects
Maki Nakayama et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Dysregulated Toll-Like Receptor-Induced Interleukin-1β and Interleukin-6 Responses in Subjects at Risk for the Development of Type 1 Diabetes
Aimon K. Alkanani et al.
DIABETES (2012)
Zinc Transporter-8 Autoantibodies Improve Prediction of Type 1 Diabetes in Relatives Positive for the Standard Biochemical Autoantibodies
Liping Yu et al.
DIABETES CARE (2012)
Medical Expenditures Associated With Diabetes Among Privately Insured U.S. Youth in 2007
Sundar S. Shrestha et al.
DIABETES CARE (2011)
Age of Islet Autoantibody Appearance and Mean Levels of Insulin, but Not GAD or IA-2 Autoantibodies, Predict Age of Diagnosis of Type 1 Diabetes
Andrea K. Steck et al.
DIABETES CARE (2011)
The pattern of inflammatory/anti-inflammatory cytokines and chemokines in type 1 diabetic patients over time
Antonios Chatzigeorgiou et al.
ANNALS OF MEDICINE (2010)
Islet inflammation and CXCL10 in recent-onset type 1 diabetes
B. O. Roep et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Enterovirus Infection and Progression From Islet Autoimmunity to Type 1 Diabetes The Diabetes and Autoimmunity Study in the Young (DAISY)
Lars C. Stene et al.
DIABETES (2010)
Altered toll-like receptor signaling pathways in human type 1 diabetes
Adam J. Meyers et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2010)
Cytokines in the Progression of Pancreatic beta-Cell Dysfunction
Chunjiong Wang et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2010)
Metabolic Syndrome and Autoimmune Diabetes: Action LADA 3
Mohammed I. Hawa et al.
DIABETES CARE (2009)
Switch from a dominant Th1-associated immune profile during the pre-diabetic phase in favour of a temporary increase of a Th3-associated and inflammatory immune profile at the onset of type 1 diabetes
Anna Ryden et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2009)
High T-helper-1 cytokines but low T-helper-3 cytokines, inflammatory cytokines and chemokines in children with high risk of developing type1 diabeties
Katerina Stechova et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2007)
The heterogeneity of diabetes - Unraveling a dispute: Is systemic inflammation related to islet autoimmunity?
Massimo Pietropaolo et al.
DIABETES (2007)
Altered chemokine levels in individuals at risk of Type 1 diabetes mellitus
P Hanifi-Moghaddam et al.
DIABETIC MEDICINE (2006)
C-reactive protein concentration is not related to islet autoimmunity status in offspring of parents with type 1 diabetes
E Bonifacio et al.
CLINICAL IMMUNOLOGY (2005)
Prevention of type 1 diabetes:: from the view point of β cell damage
E Kawasaki et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2004)
Brief communication: Early appearance of islet autoantibodies predicts childhood type 1 diabetes in offspring of diabetic parents
M Hummel et al.
ANNALS OF INTERNAL MEDICINE (2004)
Diabetes antibody standardization program: First assay proficiency evaluation
PJ Bingley et al.
DIABETES (2003)
Serum concentrations of the interferon-γ-inducible chemokine IP-10/CXCL10 are augmented in both newly diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease
F Nicoletti et al.
DIABETOLOGIA (2002)
Share Paper
